Literature DB >> 1396727

Prevalence of Chlamydia pneumoniae antibodies in Hungary.

A Marton1, A Károlyi, A Szalka.   

Abstract

Investigation of Chlamydia pneumoniae (TWAR) antibodies in paired sera of 120 patients with various respiratory diseases revealed a prevalence of 4.2% of IgG seroconversion. IgG antibody without seroconversion was found in 83.3%. Sera of ten patients showed titers as high as 512-1024 or above. Children with no respiratory disease and blood donors in Budapest had specific IgG in 46.5% and 75.2% respectively. Prevalence of IgG antibody in children from the rural areas of Hungary was about 50% lower than in children in the capital. The high prevalence of persistent IgG, indicating earlier infection, suggests that Chlamydia pneumoniae infection may be endemic in Budapest. The small number of the serologically confirmed acute infections in hospitalized patients with pneumonia leads to the conclusion that the majority of patients with chlamydial pneumonia responds to the therapeutic regimen administered by the general practitioner and referral to hospital rarely becomes necessary.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396727     DOI: 10.1007/bf01967065

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

Review 1.  Chlamydia pneumoniae, strain TWAR.

Authors:  J T Grayston
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

2.  Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium.

Authors:  L Van Renterghem; A M Van den Abeele; G Claeys; J Plum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

Review 3.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia.

Authors:  T Forsey; S Darougar; J D Treharne
Journal:  J Infect       Date:  1986-03       Impact factor: 6.072

5.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

  5 in total
  10 in total

1.  Seroprevalence of Chlamydia pneumoniae in the normal population.

Authors:  M V Stolk-Engelaar; M F Peeters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Prevalence of antibodies to Chlamydia pneumoniae in Slovenia.

Authors:  D Kese; H Hren-Vencelj; M Socan; B Beovic; M Cizman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

3.  Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.

Authors:  Y Geng; K Berencsi; Z Gyulai; T Valyi-Nagy; E Gonczol; G Trinchieri
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 4.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel.

Authors:  M Ben-Yaakov; Z Lazarovich; S Beer; A Levin; I Shoham; I Boldur
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

6.  Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey.

Authors:  M Gencay; D Dereli; E Ertem; D Serter; M Puolakkainen; P Saikku; B Boydak; S Dereli; B Ozbakkaloglu; A Yorgancioglu; E Tez
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

7.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 8.  Epidemiology and etiology of community-acquired pneumonia.

Authors:  Lionel A Mandell
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

9.  Multi-peptide ELISAs overcome cross-reactivity and inadequate sensitivity of conventional Chlamydia pneumoniae serology.

Authors:  Kh Shamsur Rahman; Bernhard Kaltenboeck
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

10.  Presence of Chlamydophila pneumoniae DNA in blood cells is a frequent event in patients with the late stage of primary cutaneous lymphomas and with atopic dermatitis.

Authors:  Bogusław Nedoszytko; Piotr Wierzbicki; Leena Karenko; Agata Maciejewska-Radomska; Przemysław Stachewicz; Monika Zabłotna; Jolanta Gleń; Liisa Väkevä; Roman J Nowicki; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2018-06-18       Impact factor: 1.837

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.